Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL28074683 | 0.95 | THRB (0.46) | THRBTSHRALDH1A1POLBAPEX1 | |
| Acrylic Acid Methyl Ester SCHEMBL28074682 | 0.87 | THRB (0.40) | THRBTSHRALDH1A1 | |
| SCHEMBL537010 | 0.86 | TSHR (0.46) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL65281 | 0.84 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL396764 | 0.81 | TSHR (0.47) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL137795 | 0.81 | TSHR (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL3914287 | 0.81 | TSHR (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL876650 | 0.80 | TSHR (0.56) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL16537346 | 0.79 | TSHR (0.42) | THRBTSHRALDH1A1 | |
| SCHEMBL21066734 | 0.79 | TSHR (0.58) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | claimed |
| EP-1469002-A1 | Method for stabilizing unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2004-10-20 | — | — | EP | claimed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| EP-3585851-B1 | AIR AND WATER BARRIER ARTICLE INCLUDING INELASTIC POROUS LAYER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4608880-A1 | RUBBER COMPOSITION | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2025-09-03 | — | — | EP | disclosed |
| US-12403671-B2 | Roll including air and water barrier article and method of using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3108076-B1 | EASY TO APPLY AIR AND WATER BARRIER ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-03-26 | — | — | EP | disclosed |
| US-12227936-B2 | Tape, article including tape and composite layer, and related methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-20240218104-A1 | FUNCTIONAL COPOLYMER OF A 1,3-DIENE AND ETHYLENE OR A 1,3-DIENE, ETHYLENE AND AN ALPHA-MONOOLEFIN | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2024-07-04 | — | — | US | disclosed |
| WO-2024088776-A1 | RUBBER COMPOSITION | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2024-05-02 | — | — | WO | disclosed |
| EP-3337867-B1 | AIR AND WATER BARRIER ARTICLE WITH POROUS LAYER AND LINER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-1736511-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734079-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | Kaneka Corporation (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1731574-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1731573-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| WO-2006117338-A2 | MOISTURE-CURABLE COMPOSITION FEATURING INCREASED ELASTICITY | SIKA TECHNOLOGY AG (CH) | 2006-11-09 | — | — | WO | disclosed |
| EP-1717254-A1 | Moisture-curable composition with improved elongation | Sika Technology AG (CH) | 2006-11-02 | — | — | EP | disclosed |
| US-6815554-B2 | REACTING A HALOALKYLSILANE WITH A SALT OF AN UNSATURATED CARBOXYLIC ACID IN THE PRESENCE OF A PHASE TRANSFER CATALYST; BONDING AGENTS | WACKER-CHEMIE GMBH (DE) | 2004-11-09 | — | — | US | disclosed |
| US-20020151736-A1 | PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS | WACKER-CHEMIE GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| EP-1249454-A1 | Preparation of unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2002-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | THRB 4533/4885TSHR 4650/4885ALDH1A1 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.